---
title: 'Mineralocorticoid receptor antagonist use and the effects of empagliflozin
  on clinical outcomes in patients admitted for acute heart failure: findings from
  EMPULSE'
date: '2023-08-04'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37540060/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230804180814&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: In patients admitted for AHF, initiation of empagliflozin
  produced clinical benefit and was well tolerated irrespective of background MRA
  use. These findings support the early use of empagliflozin on top of MRA therapy
  in patients admitted for AHF. This article is protected by copyright. All rights
  ...'
disable_comments: true
---
CONCLUSIONS: In patients admitted for AHF, initiation of empagliflozin produced clinical benefit and was well tolerated irrespective of background MRA use. These findings support the early use of empagliflozin on top of MRA therapy in patients admitted for AHF. This article is protected by copyright. All rights ...